Only a limited number of studies included women with a hereditary high‐risk profile (i.e., BRCA1/2 pathogenic variant carriers, Lynch syndrome patients and/or PHTS patients). The gene discussed is BRCA1; the disease is PTEN hamartoma tumor syndrome.